Press Releases

 Filter by Provider

Five9, Inc. (NASDAQ:FIVN), the Intelligent CX Platform provider, today reported results for the fourth quarter and full year ended December 31, 2025.

EVERTEC, Inc. (NYSE: EVTC) (“EVERTEC” or the “Company”) today announced that its Board of Directors (the “Board”) declared a regular quarterly dividend of $0.05 per share on February 19, 2026 to be paid on March 6, 2026 to stockholders of record as of March 2, 2026.

Bumble Inc. (NASDAQ: BMBL) today announced that it will report financial results for the fourth quarter and full year ending December 31, 2025, following the close of market on Wednesday, March 11, 2026. The Company will host a live webcast of its conference call to discuss the results at 4:30 p.m. Eastern Time on that day.

Workiva Inc. (NYSE: WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced financial results for its fourth quarter and full year ended December 31, 2025.

Onto Innovation Inc. (NYSE: ONTO) (“Onto Innovation,” “Onto,” or the “Company”) today announced financial results for the fourth quarter and full year 2025.

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update.

Weave Communications, Inc. (“Weave”) (NYSE: WEAV), a leading vertical SaaS platform that delivers AI-powered patient engagement and payment solutions for small and medium-sized healthcare practices, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

National CineMedia, Inc. (NASDAQ: NCMI), the managing member of National CineMedia, LLC (“NCM LLC”), the operator of the largest cinema advertising platform in the U.S., plans to issue its fourth quarter and full year 2025 earnings results after the market closes on Thursday, February 26, 2026. A conference call and audio webcast to discuss the results will take place at 5:00 p.m. Eastern Time.

WD-40 Company (NASDAQ: WDFC), a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories, and homes around the world, announced today the appointment of Ken Plunk to its board of directors, effective February 18, 2026. Mr. Plunk will serve as a member of the Audit and Finance Committees.

Warrior Met Coal, Inc. (NYSE: HCC) (“Warrior” or the “Company”) announced the publication of its 2025 Corporate Responsibility Report, now available for download on the Company’s website at www.warriormetcoal.com/sustainability. The 2025 report highlights the Company’s continued efforts on mining safely and responsibly.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and full year ended December 31, 2025.

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the fourth quarter and full year 2025. In addition, the Company provided business highlights and 2026 financial guidance.

Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2025 will be released on March 4, 2026, after market close.

Company to Host Conference Call on Friday, February 20, 2026, at 11:00 a.m. Eastern Standard Time

Increases 2026 capital return objectives to up to $800 million and renews normal course issuer bid

AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions, announced today its board of directors has authorized quarterly cash dividends for common and preferred stock for the first quarter of 2026.

Full-year 2025 revenue from continuing operations grew 14% YoY for the second consecutive year

Exceeded Q4 2025 Outlook for Revenue and Adjusted EBITDA, with Strong Adjusted Free Cash Flow

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.

October 2025 acquisition cohort tracking as best-performing October in Company history; acquisitions increased 46% quarter-over-quarter while inventory days in possession reduced 23%

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025.

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the launch of an underwritten public offering of $100 million of its common stock. Candel also intends to grant the underwriters a 30-day option to purchase up to an additional $15 million in shares of its common stock on the same terms and conditions. All shares of common stock to be sold in the offering will be offered by Candel. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

PALO ALTO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Wealthfront Corporation (Nasdaq: WLTH), a tech-driven financial platform helping digital natives turn their savings into wealth, today announced that it will release fiscal fourth quarter and full year 2026 financial results after the U.S. financial markets close on Wednesday, March 11, 2026.

Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market

IRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at TD Cowen’s 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am Eastern Time (7:30 am Pacific Time).

MENLO PARK, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for January 2026.

SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference.

By Attorney Lara Akinlude, Dual-Qualified Attorney (U.S. & UK), Larhdel Law

Dropbox, Inc. (NASDAQ: DBX), today announced financial results for its fourth quarter and fiscal year ended December 31, 2025.

AM Best has removed from under review with developing implications and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Puritan Life Insurance Company of America (Puritan) (Scottsdale, AZ). The outlook assigned to these Credit Ratings (ratings) is stable.

Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced that Don Clark has been appointed as the company’s new chief merchandising officer and Amanda “Mandy” Rassi has been appointed as the company’s chief customer officer. In conjunction with Clark’s appointment, Scott Neal, the company’s current chief merchandising officer, will be retiring from the company.

Alarm.com Holdings, Inc. (Nasdaq: ALRM), the leading platform for intelligently connected properties, today reported financial results for its fourth quarter and full year ended December 31, 2025. Alarm.com also provided its financial outlook for SaaS and license revenue for the first quarter of 2026 and guidance for the full year 2026.

Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week fourth quarter and 52-week year ending December 28, 2025.

On track for 6 proof-of-concept readouts in 2026 across the SKYLINE and SKYWAY Phase 2 trials 

SCOTTSDALE, Ariz., Feb. 19, 2026 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its Board of Directors has declared a quarterly dividend of $0.07 per share. The cash dividend will be paid on March 18, 2026, to shareholders of record as of the close of business on March 4, 2026.

Intermountain Children’s Health Launches the Nation’s Largest Pediatric Telestroke Network to Reduce Debilitating and Deadly Effects of Strokes in Children

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering are to be sold by TriSalus. In addition, TriSalus intends to grant the underwriters a 30-day option to purchase up to 15% of the total number of shares of common stock sold in the offering, on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of Aliado Seguros S.A. (Aliado) (Panama).

Perdoceo Education Corporation (NASDAQ: PRDO), a provider of postsecondary education programs through its academic institutions, today reported operating and financial results for the quarter and year ended December 31, 2025.

Armada Acquisition Corp. III (the “Company” or “AACI”) announced today the closing of its initial public offering of 24,850,000 units, including partial exercise of an over-allotment option, at $10.00 per unit. The offering resulted in gross proceeds to the Company of $248,500,000. The units began trading on the Nasdaq Global Market (“Nasdaq”) on February 18, 2026 under the ticker symbol "AACIU". Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “AACI” and “AACIW,” respectively.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.

Rimini Street, Inc., (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the 2025 fourth quarter and fiscal year ended December 31, 2025.

Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates.

Record performance in MPC and Operating Assets segments drive strong full year results as HHH begins new era as diversified holding company

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced a $100 million royalty funding agreement with funds managed by RTW Investments, LP (RTW), subject to FDA approval of aglatimagene in intermediate- to high-risk, localized prostate cancer.

Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board

BOSTON HEIGHTS, Ohio, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omnichannel retailer of premium artisan-crafted home furnishings, will release its fourth quarter and full year 2025 results on Thursday, February 26, 2026, before the stock market opens, followed by a conference call to review the Company’s financial and operational results at 8:30 a.m. Eastern Time.

IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million

By Attorney Lara Akinlude, Dual-Qualified Attorney (U.S. & UK), Larhdel Law